Management of Acute and Recurrent Gout

Publication Date: January 1, 2017
Last Updated: March 14, 2022

Recommendations

ACP recommends that clinicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine to treat patients with acute gout. (SH)
565
ACP recommends that clinicians use low-dose colchicine when using colchicine to treat acute gout. (SM)
565
ACP recommends against initiating long-term urate-lowering therapy in most patients after a first gout attack or in patients with infrequent attacks. (SM)
565
ACP recommends that clinicians discuss benefits, harms, costs, and individual preferences with patients before initiating urate-lowering therapy, including concomitant prophylaxis, in patients with recurrent gout attacks. (SM)
565

Recommendation Grading

Overview

Title

Management of Acute and Recurrent Gout

Authoring Organization

American College of Physicians

Publication Month/Year

January 1, 2017

Last Updated Month/Year

January 16, 2024

Supplemental Implementation Tools

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout.

Target Patient Population

Adults with acute or recurrent gout

Target Provider Population

All clinicians

Inclusion Criteria

Female, Male, Adolescent, Adult, Older adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Assessment and screening, Management, Treatment

Diseases/Conditions (MeSH)

D006073 - Gout, D000067251 - Symptom Flare Up, D015210 - Arthritis, Gouty, D006074 - Gout Suppressants, D033461 - Hyperuricemia

Keywords

gout, hyperuricemia, acute gout

Methodology

Number of Source Documents
94
Literature Search Start Date
January 1, 2010
Literature Search End Date
March 1, 2016